Verrica Pharmaceuticals VRCA
NASDAQ VRCA
$3.83 +0.20 (+5.51%)
At close: Oct 22, 2026 · 4:00 PM EDT

Verrica Pharmaceuticals (VRCA) Amortization of Deferred Charges (2023 - 2026)

Updated

Analysis

Verrica Pharmaceuticals (VRCA) Amortization of Deferred Charges (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn
10 Verrica Pharmaceuticals 79.47 Mn -3.58 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 113,000.00
Mar 31, 2026 100,000.00
Dec 31, 2025 100,000.00
Sep 30, 2025 88,000.00
Jun 30, 2025 81,000.00
Mar 31, 2025 84,000.00
Dec 31, 2024 137,000.00
Sep 30, 2024 187,000.00
Jun 30, 2024 156,000.00
Mar 31, 2024 138,000.00
Dec 31, 2023 20,000.00
API Access

Verrica Pharmaceuticals Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=VRCA&period=max&api_key=YOUR_API_KEY